I schemic cardiovascular events are the leading cause of morbidity and mortality in Western society. These diseases are uncommon in women before menopause, and postmenopausal estrogen replacement therapy decreases their incidence markedly, suggesting that estrogen protects against vascular disease.
1-3 Although the beneficial effects of estrogen have been attributed previously to indirect effects of estrogen on classic risk factors, recent data suggest that these do not account for the majority of the protective cardiovascular effects of estrogen. [4] [5] [6] [7] [8] Indeed, estrogen is now recognized to have direct effects on the blood vessel wall that are central to the beneficial effects of estrogen on vascular physiology and disease (reviewed in References 9 and 10).
Many of the effects of estrogen on its nonvascular target cells are mediated through the first ER identified, a ligandactivated transcription factor now called ER␣ (reviewed in References 11 to 13). Very recently, a second ER capable of regulating gene expression, ER␤, was cloned from rat prostate tissue 14 as well as from mice 15 and humans. 16 Although some domains of ER␣ and ER␤ are homologous and share functional similarities, new data suggest differences in their tissue localization and in the mechanisms regulating their transcriptional activities. 14 -17 ER␣ is known to be expressed 18 -20 and functional 19 in vascular smooth muscle cells from male and female animals and humans, and functional ER␣ has been demonstrated recently in vascular endothelial cells as well. [21] [22] [23] However, ER␤ expression in vascular tissues after injury has not yet been studied.
At least 2 direct effects of estrogen on vascular function have been described: rapid effects on vasomotor tone and longer-term effects on vascular cell proliferation and atherosclerosis (reviewed in References 9 and 10). Physiological estrogen replacement markedly suppresses the carotid arterial response to injury to the same degree in female wild-type and ER␣KO mice. 24, 25 These female ER␣KO mice express mRNA for ER␤ in their aortas, 25 suggesting that this receptor may mediate the protective effects of estrogen in the ER␣KO mice. In the present study, we sought to test the hypothesis that male animals also express ER␤ and to explore the expression of ER␣ and ER␤ mRNA in male blood vessels after vascular injury.
Materials and Methods

Animal Studies
In situ studies were on tissues from 15 intact male Sprague-Dawley rats (400 g, 3 to 4 months old, Taconic, Germantown, NY). All studies were carried out with the approval of the Institutional Animal Care and Use Committee. All surgical procedures were carried out under general anesthesia by intraperitoneal injection of xylazine (2.2 mg/kg, AnaSed, Lloyd Laboratories) and ketamine (50 mg/kg body wt, Ketaset, Aveco Co, Inc). Early time points of wounded endothelium (10 hours and 2 days) were studied in the partially denuded rat aorta by passing an uninflated catheter along the vessel. Later time points (8 days, 2 weeks, and 4 weeks) were examined in vessels from which the endothelium was removed completely by passing an inflated embolectomy catheter along the vessel as described by Clowes et al. 26 We have previously published illustrations of this procedure, 29, 30 which in the aorta leads to outgrowth of endothelium from the intercostal arteries and the appearance of smooth muscle cells in the intima within 7 days after denudation. Since the normal rat aorta and carotid artery have no intimal smooth muscle cells, endothelial cells (and a rare inflammatory cell) are the only cell types present in the intima at time points earlier than 4 days. All rats were injected with Evans blue before they were killed to identify the areas of endothelial outgrowth. On en face preparations, endothelial cells were readily distinguished from smooth muscle cells by use of the following criteria: Endothelial cells are identifiable as a single coherent layer of cells originating from the intercostal arteries with oblong nuclei equidistant from each other and oriented with blood flow. 29, 30 Smooth muscle cells, on the other hand, appear anywhere within the denuded area, have randomly oriented nuclei that frequently overlap, and appear in multiple layers. The Häutchen technique reliably removes the entire luminal cell layer for examination; smooth muscle cells appear on the en face preparations as they migrate into the region of the lumen, which occurs only after day 4 in this model. The vasculature of all animals was perfusionfixed with phosphate (0.1 mol/L, pH 7.4) buffered with 4% paraformaldehyde. For in situ hybridization and immunostaining, rats were killed at the indicated times after injury (between 4 hours and 4 weeks).
In Situ Hybridization
For en face preparations, vessel segments were cut open longitudinally, and the tissue was pinned out flat on polytetrafluoroethylene (Teflon) cards (luminal side facing up). Incubation with proteinase K (1 g/mL, 37°C, Boehringer Mannheim Corp) took place for 15 minutes, followed by prehybridization for 2 hours with 0.3 mol/L NaCl/20 mmol/L Tris (pH 7.5)/5 mmol/L EDTA/1ϫ Denhardt's solution/10% dextran sulfate/10 mmol/L dithiothreitol/50% formamide. T3 and T7 polymerase (Promega Corp) were used to generate both sense and antisense strand 35 S-UTP-labeled riboprobes. For ER␣, a 195-bp riboprobe corresponding to the 3Ј end (F domain) of the published rat sequence 31 was generated from linearized pBluescript containing this B5TX1-EcoR1 fragment of the receptor. For ER␤, a 400-bp riboprobe (EcoR1-AccI fragment) from the 5Ј untranslated region of the rat ER␤ 14 was generated. This riboprobe has been validated by separate studies on nonvascular tissues and gives results similar to 2 separate and distinct ER␤ riboprobes in testis, prostate, and ovary tissue studies (see Reference 32) . For ER␣, 17 separate specimens were hybridized with the antisense probe, and 5 were hybridized with the sense probe. For ER␤, 18 separate specimens were hybridized with the antisense probe, and 5 were hybridized with the sense probe. Photographs were taken from 14 different animals, with Ն8 preparations per aorta. After hybridization (at 55°C overnight), specimens were washed with 2ϫ SSC/ 10 mmol/L ␤-mercaptoethanol/1 mmol/L EDTA (twice for 10 minutes each) (1ϫ SSC contains 150 mmol/L NaCl and 15 mmol/L sodium citrate, pH 7.0), treated with RNase A (20 g/mL for 30 minutes at 37°C, Sigma Chemical Co), and washed in 2ϫ SSC (as above), followed by a high-stringency wash at 55°C for 2 hours (0.1ϫ SSC/10 mmol/L ␤-mercaptoethanol/1 mmol/L EDTA). Subsequent steps followed the protocol as described. 29 The Häutchen procedure for en face preparations was carried out after the probe hybridization. Slides were coated with autoradiographic emulsion (Kodak, NTB2), exposed for 3 weeks, and then developed (Kodak, D-19). Vessel preparations were observed under the light microscope using dark-field, bright-field, and a combination of epiluminescence and bright-field illumination (reflective light). Estimates of ER␣ and ER␤ mRNA were made by comparison of sense or background signal with those at each of the various time points and quantified according to an arbitrary scale (see Table legend ) by an experienced observer (V.L.) blinded to probe identity and animal treatment.
Results
ER␣ and ER␤ mRNA Expression in Male Animals After Vascular Injury
We have shown previously using RT-PCR methods that aortic vessels from female wild-type and ER␣-disrupted (ER␣KO) mice express mRNA for ER␤ at qualitatively similar levels. 25 To examine the expression of mRNA for ER␣ and ER␤ after vascular injury, the surface cells of uninjured or balloon-injured rat aortas were studied using the en face (Häutchen) technique. 29 This procedure allows study of the surface endothelial and intimal smooth muscle cells migrating into the region as a single monolayer and provides a sensitive method for studying gene expression in these 2 cell populations. The en face technique was used to study expression of both ER␣ and ER␤ in uninjured endothelial cells (the intact and normal vascular lining) as well as in endothelial cells localized to the advancing endothelial cell edge at various time points after injury. Since smooth muscle cells are observed in such preparations only at 4 to 8 days after injury, 29 ER␣ and ER␤ expression in smooth muscle cells in the en face section were examined and compared at 8, 14, and 28 days after balloon injury. The 
28-day Ϯ Ϯ
Uninj indicates control, uninjured aorta; edge, edge of endothelial cells advancing to cover the area of injury; 0, background; Ϯ, some cells slightly above background; ϩ, low levels; ϩϩ, medium levels; and ϩϩϩ, high levels of cell-specific hybridization. At each time point, 2 or 3 animals were studied. For ER␣, 17 separate specimens were hybridized with the antisense probe, and 5 were hybridized with the sense probe. For ER␤, 18 separate specimens were hybridized with the antisense probe, and 5 were hybridized with the sense probe. A minimum of 8 preparations per aorta were made for in situ analysis from each specimen. On each of these, between 10 and 30 fields were examined at ϫ400 for each determination.
sion by vascular endothelial cells was very modest in all cases and was barely above background at all time points examined (Table and Figure 1) . Similarly, smooth muscle cells also expressed very little ER␣ mRNA after injury (Table and Figure 1 ).
In contrast, ER␤ was clearly expressed in both vascular endothelial cells and smooth muscle cells in the aortas of male rats after injury. For endothelial cells, ER␤ mRNA was moderately increased at the leading edge of endothelial cells by 2 days after balloon injury, and by 8 days leading edge endothelial cells showed high levels of expression of ER␤ mRNA (Table and Figure 2 ). This high level of expression of ER␤ in endothelial cells at the leading edge persisted at day 14 after injury. Expression levels of ER␤ behind the leading edge were similar to those seen in normal (uninjured) endothelium in sections examined (data not shown).
Expression of ER␣ and ER␤ in luminal smooth muscle cells was also examined. The en face technique does not allow determination of baseline gene expression in smooth muscle cells of normal vessels and allows study only of smooth muscle cells that migrate into the region of the luminal surface Ն4 days after vascular injury. This population of smooth muscle cells thus differs from other intimal or medial smooth muscle cell populations in the vessel wall.
However, once smooth muscle cells have appeared on the luminal surface (ie, 8 days and 2 and 4 weeks), comparison of ER␣ and ER␤ mRNA expression between time points is possible. After injury, ER␤ mRNA was moderately abundant in luminal smooth muscle cells at both 8 and 14 days, and in all cases, ER␤ message was significantly greater than that for ER␣ in these cells (Table and Figure 3) . By 28 days, the level of expression of ER␤ mRNA in the smooth muscle cell population had decreased to very low levels compared with those seen at the 8-day and 2-week time points.
Discussion
The present study demonstrates the expression of ER␤ mRNA in male rat aortas before and after balloon denudation injury. The level of expression of mRNA for the ER␣ and ER␤ after balloon injury of male rat aortas was strikingly different in these studies. ER␣ mRNA was expressed only at very low levels in vascular endothelial and smooth muscle cells after injury. ER␤ mRNA expression, however, increased to high or very high levels in vascular endothelial cells after injury. In the smooth muscle cells that appeared at the luminal surface after injury, ER␤ mRNA was abundant at both 8 days and 2 weeks but declined to near baseline levels by 28 days after injury. Estrogen inhibits the response to vascular injury in a variety of animal models. 24, 25, [33] [34] [35] [36] [37] [38] [39] [40] [41] In particular, rat vascular tissues express functional estrogen, 42 and estradiol inhibits myointimal proliferation after carotid balloon injury in gonadectomized male rats, 39, 40 the animal studied in these experiments. The high levels of ER␤ expression in vascular cells of injured male vessels in these studies, without significant changes in ER␣ expression, are striking and raise the possibility that ER␤ may mediate some of the protective effects of estrogen in the setting of vascular injury. This hypothesis is consistent with the presence of ER␤ in the aortas of ER␣KO mice and the ability of estradiol to inhibit the vascular response to injury in these animals to the same degree as in their wild-type littermates. 25 Upstream regulatory regions of the ER␤ gene important to the observed induction of ER␤ message after vascular injury remain to be defined, and the potential growth factors or other stimuli induced by balloon injury that lead to increased ER␤ expression also are presently unclear. However, the observed increase in mRNA for ER␤ after balloon injury suggests that study of ER␤ may be important in the understanding of the direct vascular protective effects of estrogen. It will be important in subsequent studies to define carefully the relative abundance of ER␤ Figure 2 . Photomicrographs of en face preparations showing ER␤ mRNA expression in vascular endothelial cells in male rat aorta after balloon injury. In situ hybridization using 35 S-UTP-labeled riboprobes for rat ER␤ is shown. Arrows depict leading endothelial cell edge. A, Sense probe is seen in uninjured en face preparation of endothelial cell monolayer. B, Antisense probe in uninjured endothelial cell monolayer detects no ER␤ mRNA in the uninjured endothelium. C to F, ER␤ mRNA also was not increased in the endothelial cells at the wound edge at 10 hours (C) but was clearly increased at 2 days after injury (D) and was markedly increased at 8 days (E) and 2 weeks (F) after injury. All photomicrographs are representative examples obtained from 10 to 30 high-power fields (ϫ400). Barϭ20 m.
mRNA and protein in vascular cells and tissues from intact and ovariectomized female animals after injury. Furthermore, careful analysis of ER␣ and ER␤ mRNA protein in vascular cells and tissues under various conditions will be important, including human cells and tissues from men, premenopausal women, and postmenopausal women, both untreated and on hormone replacement therapy. It will be especially important to examine cell culture expression of the ERs and to correlate in vitro with in vivo expression. Preliminary RT-PCR studies indicate that ER␤ is expressed in male and female vascular cells (data not shown), but it is already apparent that expression levels of ER␤ mRNA, like those of ER␣, vary with culture conditions, passage, and vascular bed of origin (see Reference 23) . It will also be important to understand regional differences in the vascular expression of ER␤ in vivo and to examine specifically the role of ER␤ in mediating the vascular protective effects of estrogen. The recent development of ER␤-specific antagonists and the ER␤ knockout mouse will allow this latter topic to be studied directly. 
